Pipeline
From Data to Drug candidates in Months Not Years
From Data to Drug candidates in Months Not Years
From Data to Drug candidates in Months Not Years
Next-generation, multi-target drug candidates for safe, more effective patient outcomes
Next-generation, multi-target drug candidates for safe, more effective patient outcomes.
2023
Research & Data
Neurological Disorder #2
Cancer #1
In-Silico
Neurological Disorder #1
Metabolic Disorder #1
Initial Synthesis
PTSD
A novel approach to Post-Traumatic Stress Disorder.
In-Vitro
SUD ― Cocaine
Combatting opioid use through targeted therapies.
In-Vivo
OUD ― Fentanyl
Combatting opioid use through targeted therapies.
IND
2024
Research & Data
Autoimmune Disease #1
Metabolic Disorder #2
Metabolic Disorder #3
Neurological Disorder #3
Autoimmmune Disease #2
Neurological Disorder #4
In-Silico
Initial Synthesis
In-Vitro
In-Vivo
IND
2023
OUD ― Fentanyl
Combatting opioid use through targeted therapies.
SUD ― Cocaine
Advancing innovative treatments to address cocaine substance use disorder.
PTSD
A novel approach to Post-Traumatic Stress Disorder.
Neurological Disorder #1
Metabolic Disorder #1
Neurological Disorder #2
Cancer #1
Research & Data
In-Silico
Initial Synthesis
In-Vitro
In-Vivo
IND
2024
Autoimmune Disease #1
Metabolic Disorder #2
Metabolic Disorder #3
Neurological Disorder #3
Autoimmmune Disease #2
Neurological Disorder #4
Research & Data
In-Silico
Initial Synthesis
In-Vitro
In-Vivo
IND
Contacts
Join Us in Transforming Medicine Through Advanced AI
We're always on the lookout for like-minded partners committed to making healthcare better, more efficient, and safer. Reach out today to see how our specialized AI solutions can be tailored to your needs.
© 2024 GATC Health Corp. All rights reserved.
© 2024 GATC Health Corp. All rights reserved.
© 2024 GATC Health Corp. All rights reserved.